Forward Pharma A/S
FWPAY · OTC
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $70,770 | $79,087 | $77,598 | $82,542 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $140 | $287 | $273 | $448 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $0 | $0 | $0 |
| Total Curr. Assets | $71,402 | $79,711 | $78,163 | $83,330 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $3 | $3 | $2 | $2 |
| Total NC Assets | $3 | $3 | $2 | $2 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $71,405 | $79,714 | $78,165 | $83,332 |
| Liabilities | – | – | – | – |
| Payables | $70 | $476 | $82 | $428 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $68 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $538 | $594 | $514 | $622 |
| Total Curr. Liab. | $608 | $1,070 | $596 | $1,118 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $608 | $1,070 | $596 | $1,118 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $157 | $154 | $152 | $152 |
| Retained Earnings | -$16,716 | -$14,825 | -$8,432 | -$5,686 |
| AOCI | $87,356 | $93,315 | $85,849 | $87,748 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $70,797 | $78,644 | $77,569 | $82,214 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $71,405 | $79,714 | $78,165 | $83,332 |
| Net Debt | -$70,770 | -$79,087 | -$77,598 | -$82,542 |